Sex steroids have been shown to increase VEGF expression in normal breast tissue as well as in experimental breast cancer, both in vitro and in vivo [6-10], and an estrogen responsive element (ERE) has been identified in the promoter region of the gene for VEGF [11]. The gene discussed is VEGFA; the disease is breast carcinoma.